Skip to main content
Premium Trial:

Request an Annual Quote

Ocimum Biosolutions Signs Marketing and Distribution Agreement with Science-Partners

NEW YORK, Aug. 31 (GenomeWeb News) - Ocimum Biosolutions said today that it has signed a marketing agreement with UK-based Science-Partners related to the marketing and distribution of Laboratory Information Management Systems.


Under the terms of the agreement, Science-Partners, based in Oxford, will market and distribute Indianapolis-based Ocimum's LIMS, including Biotracker, Pharmatracker, and Toxcheck, in the UKand North European markets. Science-Partners will also market Ocimum's bioinformatics and gene optimization tools, including Genchek, Genowiz, RNAchek, Optgene, and Nutrabase in the UKand Europe.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.